highperformr logo

Gero's Overview

Total employees100
HeadquartersSingapore
Founded2018

Gero is a pioneering biotechnology company dedicated to understanding the fundamental biology of aging and developing novel therapeutics to combat age-related diseases and extend healthy human lifespans. Leveraging advanced AI and machine learning, Gero analyzes large-scale biological data, including human health records and genetic information, to identify new drug targets and develop interventions aimed at slowing or reversing the aging process. Their research focuses on areas like resilience to stress and disease, with the ultimate goal of creating therapies that enhance healthspan and treat complex conditions.

Where is Gero's Headquarters?

HQ Function

Serves as the central hub for Gero's research and development leadership, strategic planning, global operations management, and business development in the field of longevity and AI-driven drug discovery.

Notable Features:

Located in International Plaza, a well-known high-rise commercial and residential building in Singapore's Central Business District. The office is expected to house advanced computational infrastructure necessary for its AI-driven research and data analysis.

Work Culture:

Gero likely fosters a highly innovative, collaborative, and research-intensive environment, bringing together experts in AI, computational biology, physics, and drug development. The culture probably emphasizes cutting-edge science, data-driven decision-making, and a strong mission-driven focus on tackling aging and improving human healthspan.

HQ Significance:

The Singapore HQ is significant due to its access to a strong talent pool, supportive government initiatives for biotech and AI, robust intellectual property protection, and its position as a gateway to the broader Asian market and global scientific collaborations.

Values Reflected in HQ: The choice of a modern, well-connected business hub in a global city like Singapore reflects Gero's commitment to innovation, global collaboration, scientific excellence, and leveraging advanced technology to achieve its ambitious mission in longevity research.

Location:

Gero operates with a global mindset, anchored by its headquarters in Singapore and a significant presence in the key biotechnology hub of Cambridge, Massachusetts, USA. This dual presence allows the company to engage with leading scientific communities, recruit top talent internationally, foster global research collaborations, and pursue business development opportunities across Asia, North America, and Europe. Gero's AI-driven platform inherently supports distributed data analysis and collaboration, enabling its team to work on a global scale to advance the science of longevity.

Street Address:

10 Anson Road, #27-18, International Plaza

City:

Singapore

State/Province:

Singapore

Country:

Singapore

Gero's Global Presence

Cambridge, Massachusetts, USA

Address: Specific street address not publicly listed, likely a research or business development office within the Cambridge/Boston biotech hub.

To tap into the world-class talent pool, leading academic research institutions, and the vibrant venture capital network concentrated in one of the world's foremost biotechnology clusters, advancing Gero's drug discovery programs targeting aging.

Buying Intent Signals for Gero

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Gero

As of April 2025, Gero' leadership includes:

Peter Fedichev, PhD - CEO, Co-founder
Maxim Kholin, PhD - COO, Co-founder
Mischaela Litscher - Head of Business Development
Timothy Pyrkov, PhD - Head of R&D
Polina Mamoshina, PhD - Head of AI
Andrey Lovat, MD, PhD - Head of Clinical Development

Investors of Gero

Gero has been backed by several prominent investors over the years, including:

Target Global
Melnichek Investments
Flint Capital
Sberbank Investments (now SberInvestments)
Vladimir Potanin (through an investment vehicle)
Bulat Utemuratov (through an investment vehicle)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In the last 12 months (May 2023 - May 2024), Gero significantly strengthened its clinical development capabilities with the strategic appointment of Dr. Andrey Lovat as Head of Clinical Development. No major executive departures have been publicly announced during this period, indicating stability in its core leadership team.

New Appointments:

Andrey Lovat, MD, PhD, Dr. Andrey Lovat joined Gero as Head of Clinical Development, bringing extensive experience in clinical research, drug development, and regulatory affairs to the company, aiming to accelerate the translation of Gero's discoveries into human therapies.

Technology (Tech Stack) used by Gero

Discover the tools Gero uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Gero Email Formats and Examples

Gero primarily utilizes the email format consisting of the employee's first name followed by a period, then their last name, all preceding '@gero.ai'. This is a common and professional email structure in the technology and biotechnology sectors.

first.last@gero.ai

Format

peter.fedichev@gero.ai

Example

85%

Success rate

News and media

BioSpaceApril 18, 2024

Gero AI Identifies Novel ALS Targets, Validates Them In Vivo

Gero announced the discovery of novel therapeutic targets for Amyotrophic Lateral Sclerosis (ALS) using its AI platform. These targets were subsequently validated in vivo in animal models, highlighting a potential new avenue for developing treatments for the debilitating neurodegenerative disease....more

Business WireMarch 27, 2024

Gero Publishes Study With Pfizer Showing Potential For Burden Of Disease Reversal via AI

Gero, in collaboration with Pfizer, published research in a peer-reviewed journal demonstrating that AI can identify interventions capable of reversing the biological burden of age-related diseases. This study suggests a new paradigm for therapeutic development in chronic illnesses by focusing on resilience and aging clocks....more

Business WireJuly 20, 2023

Gero Appoints Dr. Andrey Lovat as Head of Clinical Development

Gero announced the appointment of Andrey Lovat, MD, PhD, as its Head of Clinical Development. Dr. Lovat brings significant experience in clinical research and drug development to Gero and will lead the company's efforts to translate its AI-driven discoveries into clinical therapies....more

Longevity.TechnologyJuly 10, 2023

Gero AI Model Links Aging to Resilience Decline

Gero published research detailing an AI model that quantifies the link between the aging process and a decline in physiological resilience. This model offers new insights into the mechanisms of aging and could lead to the development of novel biomarkers and interventions for age-related conditions....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Gero, are just a search away.